相关实验视频

Updated: May 2, 2026

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

巴洛的集中性硬化症成功地用阿姆图祖马布治疗:长期随访

Sandra Elias¹, Todd A Hardy^1,2, Aijaz Khan³

¹Department of Neurology, Concord Hospital, Sydney, NSW, Australia.

Multiple sclerosis (Houndmills, Basingstoke, England)

|April 12, 2025

概括

阿拉姆图祖马布可能对巴洛集中性硬化症 (BCS) 有效,这是一种罕见的多发性硬化症 (MS) 变体. 本案例研究表明,在接受阿勒姆图祖马布治疗的BCS患者中,持续的临床和放射性反应持续了六年.

科学领域:

神经免疫学神经免疫学
神经学神经学
脱线性疾病脱线性疾病

背景情况:

巴洛集中性硬化症 (BCS) 是一种罕见的脱髓化疾病,通常被认为是多发性硬化症 (MS) 的变体.
对于BCS中MS的疾病修饰疗法 (DMT) 的疗效在很大程度上仍未确定.
以前的报道表明,对传统治疗的反应有限,并且在先进的BCS中,阿勒姆图祖马布可能缺乏疗效.

研究的目的:

评估在诊断为巴洛集中性硬化症的患者中,阿勒姆图祖马布治疗的长期临床和放射性结果.
调查阿勒姆图祖马布作为BCS早期治疗选择的潜在作用.

主要方法:

病例报告详细介绍了一个患有BCS.的单一患者.
开始用阿勒姆图祖马布治疗BCS.
在6年的随访期内进行的临床和放射性评估.

主要成果:

患者经历了显著的临床改善和持续的放射性缓解.
在6年的随访期间,阿勒姆图祖马布显示出积极的治疗效果.
在随访期间,没有报告与阿勒姆图祖马布相关的不良事件.

结论:

阿拉姆图祖马布可以作为Baló集中性硬化症的有效治疗方法,特别是当它在疾病的早期开始时.
这一案例表明,阿勒姆图祖马布可能为BCS提供一种可行的治疗选择,与先前在晚期疾病中的发现形成鲜明对比.
需要进一步的研究和更大规模的研究来证实阿姆图祖马布在BCS中的疗效和安全性.

关键词:

巴洛的集中性硬化症.亚马尔图祖马布 (Alemtuzumab) 是一种药物.多发性硬化症多发性硬化症治疗治疗治疗治疗治疗治疗瘤活动性瘤活动性

更多相关视频

$MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor$ 05:54

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor

Published on: December 13, 2017

Surgical Treatment of an Endolymphatic Sac Tumor

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

相关概念视频

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...